SG Americas Securities
AUTL

SG Americas Securities’s Autolus Therapeutics AUTL Stock Holding History

SG Americas Securities’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-66,107
Closed -$91K – 3368
2026
Q1 		$91K Sell
66,107
-571
-0.9% -$867 ﹤0.01% 2951
2025
Q4 		$133K Buy
66,678
+26,241
+65% +$40.3K ﹤0.01% 3104
2025
Q3 		$66K Buy
40,437
+3,893
+11% +$7.61K ﹤0.01% 3155
2025
Q2 		$83K Sell
36,544
-32,388
-47% -$53.6K ﹤0.01% 2674
2025
Q1 		$107K Buy
68,932
+4,316
+7% +$8.76K ﹤0.01% 2998
2024
Q4 		$152K Sell
64,616
-2,713
-4% -$9.17K ﹤0.01% 2392
2024
Q3 		$244K Sell
67,329
-121,911
-64% -$486K ﹤0.01% 2328
2024
Q2 		$659K Buy
189,240
+169,387
+853% +$731K ﹤0.01% 1530
2024
Q1 		$127K Buy
+19,853
New +$124K ﹤0.01% 2354
2022
Q1 		– Sell
-250,822
Closed -$1.3M – 2957
2021
Q4 		$1.3M Buy
+250,822
New +$1.51M 0.01% 1446
2020
Q1 		– Sell
-26,435
Closed -$349K – 3433
2019
Q4 		$349K Buy
+26,435
New +$346K ﹤0.01% 2069

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SG Americas Securities's AUTL Position: Q2 2026 in Review

SG Americas Securities sold out of Autolus Therapeutics (AUTL) in Q2 2026, closing a stake of 66,107 shares — an estimated $91K sold.

SG Americas Securities first reported a position in AUTL in Q4 2019 and held it in 11 quarters. The position peaked at $1.3M in Q4 2021. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • SG Americas Securities reported no remaining Autolus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 66,107 Autolus Therapeutics shares in Q2 2026, an estimated $91K.
  • SG Americas Securities first reported a position in Autolus Therapeutics in Q4 2019 and held it in 11 quarters.
  • SG Americas Securities's Autolus Therapeutics position peaked at $1.3M in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.